Stock listing

NB3 Stock Price, News, Filings & Events — Neurocrine Biosciences, Inc.

Selected listing: NB3 · BX · CHF · CH

The selected listing for Neurocrine Biosciences, Inc. is NB3:BX. Neurocrine focuses on developing and commercializing innovative therapies for neurological and endocrine disorders, with a strong commitment to improving patient outcomes. The company has a significant market capitalization of approximately $17.18 billion, reflecting its position in the healthcare sector. Recent news and filings highlight its ongoing efforts to address unmet medical needs within its specialized field.

NB3:BXCHFCHUpdated July 24, 2026
Neurocrine Biosciences, Inc. logo
Ticker
NB3:BX
Asset type
Stock
Market cap
$17.67B
Sector
Health Technology
Industry
Biotechnology
Exchange
BX
Currency
CHF

Neurocrine Biosciences, Inc. NB3:BX stock context

The selected listing for Neurocrine Biosciences, Inc. is NB3:BX. Neurocrine focuses on developing and commercializing innovative therapies for neurological and endocrine disorders, with a strong commitment to improving patient outcomes. The company has a significant market capitalization of approximately $17.18 billion, reflecting its position in the healthcare sector. Recent news and filings highlight its ongoing efforts to address unmet medical needs within its specialized field.

Research Neurocrine Biosciences, Inc.

Alternate listings